- Sanofi stops immune drug trial in latest research setback<p>The failure adds to a series of mixed or negative readouts and leaves in doubt the future of a therapy Sanofi has viewed as a potential blockbuster.</p>BioPharma Dive · 1mo ago↗ source
- Parabilis sets a record with a $670M biotech IPO<figure><div><img src="https://imgproxy.divecdn.com/-WtHBsuOT3KcVhU1bnMz7w4Q3nPK_9osZdC3JBWMQKI/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy00NjI3NTYxODNfeU9zU…BioPharma Dive · 1mo ago↗ source
- AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…